CUTANEOUS MANIFESTATION DURING ANTI-TNF Α THERAPY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

(1) Sapienza University , Rome, Italy



This item was part of the IBD III session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A528

You may be interested in:

CUTANEOUS MANIFESTATION DURING ANTI-TNF Α THERAPY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
English, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
SECONDARY NON RESPONSE TO ANTI-TNF IS RELATED TO ANEMIA, INCREASED WHITE BLOOD CELL ,HIGH C-REACTIVE PROTEIN AND LOW SERUM ALBUMIN
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
CHARACTERIZATION OF INCIDENT CASES OF CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A MULTICENTER CASE-CONTROL STUDY
English, Clinical aspects, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Disease
    • Inflammatory bowel disease
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013